Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3997374 | Revista Colombiana de Cancerología | 2009 | 6 Pages |
Abstract
Opiods are the current pharmalogical remedies of choice for the control of moderate to severe pain. Subsequently, it is important to rely on a number of prescriptions and applications for these drugs, particularly in the case of oncological patients. Low molecular weight, high potency and liposolubility of buprenorphine combine with its favorable tolerance and low abuse probability. Clinical evidence reveals that the use of transdermal buprenorphine in the treatment of moderate to severe pain in oncological patients is effective and safe. However, buprenorphine has not been widely studied among certain populations, as have other opiods, thus making further research necessary in order to define its role under specific clinical circumstances.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
MarÃa Catalina Soto Niño,